RARE vs TECTP · rev $560.2M vs P/E 4.6, $40.5M cap
Ultragenyx (RARE) versus Tectonic Financial Inc PR (TECTP) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Tectonic Financial Inc PR (TECTP) is a banks - regional company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
TECTP does not have a complete income-statement cache yet.
RARE currently screens at market cap $2.79B. TECTP currently screens at market cap $40.5M and trailing P/E 4.6.
Not investment advice. Open the RARE and TECTP stock pages for the full models.
Not investment advice.